Agilent Inaugurates India Solution Center to Accelerate Innovation and Expand the Frontiers of Science
Agilent today announced the opening of its first-ever India Solution Center at its LEED Platinum-certified office in Manesar, Haryana. Designed to provide integrated solutions, this strategic investment marks a major milestone in Agilent's global journey, highlighting strong focus on India as a high-growth, innovation-driven market. The facility was inaugurated in the esteemed presence of key opinion leaders and decision-makers from diverse sectors and markets that Agilent serves throughout India, who joined the ceremony to experience the center firsthand.
As India sees a rapid rise in chronic health conditions such as obesity and Type 2 diabetes, and a growing emphasis on environmental and food safety regulations, the demand for advanced, localized solutions is accelerating. The India Solution Center brings together Agilent's expertise across different disciplines to deliver holistic end-to-end solutions in sectors such as GLP-1 analysis, emerging food and environmental contaminants analysis, and PFAS detection.
'India is a strategic market for Agilent, and we are thrilled to open our state-of-the-art Solution Center in Manesar, said Jonah Kirkwood, Chief Commercial Officer at Agilent. 'This facility is designed to provide our India customers with the resources and collaboration they need to address critical scientific and health challenges. By offering holistic and specialized workflows—from sample preparation to smart and fast results reporting—we aim to boost lab efficiency, support automation, and promote sustainable practices. Our goal is to help labs meet their financial, scientific, and sustainability objectives'.
Spanning 12,500 square feet, the facility offers development of analytical workflow methods and novel applications, as well as proof-of-concept demonstration, and collaborative R&D and training. With dedicated zones for chromatography, mass-spectrometry, spectroscopy, genomics, cell analysis and lab informatics, the India Solution Center aims to address critical areas such as pharmaceutical quality control, biopharmaceutical development across modalities, food safety, environmental monitoring, cell biology, and cancer research. The center will also align with national initiatives such as 'Make in India' to advance the country's scientific and healthcare ecosystem.
'Our goal is to support our customers not only with cutting-edge technologies but also with personalized experiences that drive scientific progress and business growth,' added Bharat Bhardwaj, Vice President, APAC region, Agilent. 'The India Solution Center embodies our focus on customer partnership, end-to-end solution delivery that offer practical and tangible benefits and enable innovation throughout the research and development lifecycle.'
The center's location in Manesar, a key biopharma and research hub, ensures accessibility for customers across pharmaceutical, clinical, biopharma, food, chemical, and government sectors. The India Solution Center is part of Agilent's plan to strengthen its footprint and engagement with customers more deeply throughout India.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Andhra Pradesh government calls for tenders to fast track river linking project
1 2 3 Vijayawada: State govt is determined to launch the dream river linking project by initiating Godavari-Banakacharla major irrigation scheme. Notwithstanding the objections and uproar from the neighbouring Telangana, Andhra Pradesh govt has decided to put the project on fast track by calling tenders. The project will be taken up under the Hybrid Annuity Model (HAM). The Centre has raised several doubts about the economical feasibility of Godavari-Banakacherla project. However, the State has decided to prepare the detailed project report (DPR) in order to secure further clearances from the Centre for the Godavari diversion scheme. State-level technical committee and oversight committees will be appointed to screen the project DPR. The Polavaram–Banakacherla linkage project is being undertaken under the Jalaharathi Corporation, a special purpose vehicle (SPV). The project is expected to cost 81,900 crore. Govt requested the Centre to arrange financial assistance through external aided projects (EAP) from the multinational lending agencies and also from the Union budget. It requested the Centre to ensure that at least 50% of the project cost (₹40,950 crore) is raised as EAP loans. It requested the Centre to spare another 20% (₹16,380 crore) as grant. AP govt is getting ready to take burden to the tune of ₹8,190 crore which is 10% of the total project cost. It proposed to involve private players to share the remaining 20% load, which is around ₹16,380 crore, under the hybrid annuity model (HAM). A high-level delegation from state govt visited New Delhi and shared the details of Godavari-Banakacherla project with the senior officials from the Union finance ministry. However, Sajjan Singh Yadav, additional secretary of finance ministry,reportedly asked the state officials to explain as to how the project could be technically and financially feasible when so many lift schemes are part of it. He had also wanted to know from state govt as to what would be the fate of existing projects on Krishna river when it is proposed to divert 200 tmc ft of Godavari water to Krishna basin. He reportedly asked about the power required to operate the lift schemes, included as part of the scheme, and as to how the State wanted to generate such a huge quantum of energy. It was also said that Yadav asked the state team how they wanted to utilise the flood waters from both Krishna and Godavari simultaneously, since flood hits both the rivers either simultaneously or with little gap. Former agriculture minister and social activist, Vadde Sobhanadreeswara Rao objected the proposal to take up Godavari-Banakacherla without completion of ongoing irrigation projects. "Several projects launched during NTR regime between1983-89 could not be completed even after 40 years and also his grandson Lokesh became minister. How could we expect Godavari-Banakacharla, proposed with Rs.1 lakh crore, would be completed anytime soon?" fumed Vadde. He alleged that state govt is proposing the projects only to benefit the contractors, and not the state.
&w=3840&q=100)
First Post
6 hours ago
- First Post
40 women using weight-loss drugs see unexpected pregnancies; prompt UK's warning over contraceptives
The weight loss drugs, by mimicking gut hormones, effectively reduce appetite and promote weight loss, which can in turn boost fertility in women with obesity read more There have been at least 40 cases of unexpected pregnancies associated with weight loss drugs. Pixabay British health authorities have issued a warning to women using weight-loss medications such as Ozempic, Wegovy and Mounjaro, urging them to use effective contraception after dozens of pregnancy reports linked to the drugs. The Medicines and Healthcare products Regulatory Agency (MHRA) on Friday (May 6) released its first public safety alert addressing the use of weight-loss drugs and contraception. The agency said it had received 40 reports of pregnancies involving users of medications that include the active ingredients semaglutide or tirzepatide, The Guardian reported. STORY CONTINUES BELOW THIS AD Ozempic and Wegovy, which both contain semaglutide, mimic a gut hormone called GLP-1 that helps reduce appetite by slowing digestion and increasing insulin production. Mounjaro, which contains tirzepatide, also targets a second hormone involved in blood sugar and appetite control. Though often referred to as 'weight-loss injections,' not all of the drugs are formally authorised for weight loss. Drugs not advised during pregnancy or attempts to conceive The MHRA said the drugs should not be taken during pregnancy, while trying to conceive, or while breastfeeding due to a lack of safety data. In some cases, the agency recommends that women continue contraception for up to two months after stopping the medication before attempting pregnancy. Among the 40 reports, eight were associated with semaglutide and nine with liraglutide, which is found in the weight-loss drug Saxenda. Two cases were explicitly reported as unintended pregnancies. Dr. Channa Jayasena, a reproductive endocrinologist at Imperial College Healthcare NHS Trust, said the drugs, by mimicking gut hormones, effectively reduce appetite and promote weight loss, which can in turn boost fertility in women with obesity. 'Obesity reduces fertility in women. So, women with obesity taking GLP-1 drugs are more likely to get pregnant than before they lost weight,' he said. He also noted that the medications may interfere with the absorption of oral contraceptives due to delayed stomach emptying, although further research is needed. Officials stress responsible use Dr. Alison Cave, the MHRA's chief safety officer, warned that the medications should not be used as quick fixes for weight loss or for cosmetic purposes. 'Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments,' Cave said. 'They are not a quick fix to lose weight and have not been assessed to be safe when used in this way.' The MHRA said it has published updated guidance to help patients use the medications safely but emphasized that the advice should not replace consultation with a healthcare provider. STORY CONTINUES BELOW THIS AD Dr. Jayasena added that while the risks of GLP-1 drugs in pregnancy are not fully known, similar weight-loss interventions like surgery have been associated with higher miscarriage rates. 'So women are advised to do all they can to prevent pregnancy while taking GLP-1 drugs,' he said.
News18
11 hours ago
- News18
India poised to benefit from FTAs, says RAI CEO Kumar Rajagopalan
Singapore, Jun 8 (PTI) India has emerged as a 'great place" to use the advantages accruing from Free Trade Agreements (FTAs), a senior retail industry official said as he highlighted the success of Make in India programme. 'We are among the most attractive markets, with a growing young population that makes us one of the world's largest consumer markets with insatiable demand for the best in the world," said Retailers Association of India (RAI) CEO Kumar Rajagopalan at an event here. FTAs will also give Indians access to items that get manufactured abroad at a more convenient pricing, he added. But he was also quick to dismiss notions of dumping cheap inferior goods into the Indian market, pointing out that the country has created laws that can protect against such trade-damaging practices, and that can be challenged at the World Trade Organization. According to Kumar, a trade veteran of 40 decades, a full-fledged quality control checking system is in place to ensure Indian consumers are getting the best products as imports of edibles is set to increase following the signing of more and more FTAs by the Indian government in an endeavour to reach out the global markets. India has always imported consumer products from around the world but in recent years with the economic prosperity momentum picking up, the country has become 'more and more attractive as a consumer-driven market", given the young population with rising income seeking the best quality, cost-effective, long-lasting and appealing products, Kumar pointed out. FTAs are increasing India's bilateral trade globally, covering value-added high-end and heavy-duty industrial products to edibles such as soybeans, cheeses, vines and beverages. RAI leads about 2,500 members, mostly retailers at national level, with an annual business volume of about USD 900 billion, that is set to grow at 10 per cent annually. Kumar also sees competition from world-class products for Make in India. 'Imports and exports will create a competitive landscape and we will see further upgrades in manufacturing processes within India to make globally-rated products be it hardware, software and or edibles." India, he said, produces agri and non-agri products for consumers as well as industrial plants for the world. He said that 85 per cent of the 7,00,000 stores in India are still operating in traditional formats, ranging from the corner shop Kiraana to single store supplying everything in the range of garments and edibles, competing with mega modern-day fast-pace trading department stores, online and offline supply chain operators. Fast and quick-commerce have reduced delivery time to 10 minutes while e-commerce and online payments have made retailing business easier and prompt, he observed. A latest example of India made products from design to garment production is Mumbai-headquartered 'Fynd", an artificial intelligence-driven commerce platform that is serving the Indian market as well as the Middle East and Africa markets. NRF 2025 had 9,500 trade visitors from over 72 countries, alongside participation from 240 exhibitors and sponsors, and 150 conference speakers. PTI GS ANU First Published: June 08, 2025, 17:15 IST
